-
公开(公告)号:US20110230414A1
公开(公告)日:2011-09-22
申请号:US13039433
申请日:2011-03-03
申请人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
发明人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
IPC分类号: A61K38/00 , C07D487/04 , A61K31/4985 , A61P29/00 , A61P35/00 , A61P9/00 , A61P3/10 , A61P19/02 , A61P37/06 , A61P11/06 , A61P1/04 , A61P5/02 , A61P25/28
CPC分类号: C07D487/04
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q, R2, R3, and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量Q,R2,R3和Y如本文所述定义,其抑制JAK和SYK并且可用于治疗自身免疫和炎性疾病 。
-
公开(公告)号:US08481541B2
公开(公告)日:2013-07-09
申请号:US13039433
申请日:2011-03-03
申请人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
发明人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
IPC分类号: A61K31/495
CPC分类号: C07D487/04
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q, R2, R3, and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量Q,R2,R3和Y如本文所述定义,其抑制JAK和SYK并且可用于治疗自身免疫和炎性疾病 。
-
公开(公告)号:US08518945B2
公开(公告)日:2013-08-27
申请号:US13040310
申请日:2011-03-04
申请人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
发明人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
IPC分类号: A61K31/495
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables n, p, q, Q, X, X′ and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量n,p,q,Q,X,X'和Y如本文所述定义,其抑制JAK和SYK,并且可用于治疗 自身免疫和炎性疾病。
-
公开(公告)号:US20110230462A1
公开(公告)日:2011-09-22
申请号:US13040310
申请日:2011-03-04
申请人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
发明人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen M. Lynch , Timothy D. Owens , Michael Soth
IPC分类号: A61K31/4985 , C07D487/04 , A61P29/00 , A61P35/00 , A61P37/00 , A61P9/00 , A61P3/10 , A61P11/06 , A61P17/06 , A61P25/28 , A61K31/5377 , A61K31/541
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables n, p, q, Q, X, X′ and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量n,p,q,Q,X,X'和Y如本文所述定义,其抑制JAK和SYK,并且可用于治疗 自身免疫和炎性疾病。
-
公开(公告)号:US20110288097A1
公开(公告)日:2011-11-24
申请号:US13110053
申请日:2011-05-18
申请人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen Lynch , Timothy D. Owens , Michael Soth , Calvin Yee
发明人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen Lynch , Timothy D. Owens , Michael Soth , Calvin Yee
IPC分类号: A61K31/4985 , A61P37/02 , A61P3/10 , A61P17/02 , A61P17/06 , A61P25/28 , A61P35/02 , A61P11/06 , A61P35/00 , C07D471/04 , A61P1/00
CPC分类号: C07D487/04
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R1 and R2 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量Q和R 1和R 2如本文所述定义,其抑制JAK和SYK并且可用于治疗自身免疫和炎性疾病。
-
公开(公告)号:US08329699B2
公开(公告)日:2012-12-11
申请号:US13110053
申请日:2011-05-18
申请人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen Lynch , Timothy D. Owens , Michael Soth , Calvin Yee
发明人: Robert Than Hendricks , Johannes Hermann , Rama Kondru , Yan Lou , Stephen Lynch , Timothy D. Owens , Michael Soth , Calvin Yee
IPC分类号: A61K31/495
CPC分类号: C07D487/04
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R1 and R2 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量Q和R 1和R 2如本文所述定义,其抑制JAK和SYK并且可用于治疗自身免疫和炎性疾病。
-
公开(公告)号:US20110288067A1
公开(公告)日:2011-11-24
申请号:US13110062
申请日:2011-05-18
申请人: Robert Than Hendricks , Johannes Hermann , Saul Jaime-Figueroa , Rama Kondru , Yan Lou , Stephen Lynch , Timothy D. Owens , Michael Soth , Calvin Yee
发明人: Robert Than Hendricks , Johannes Hermann , Saul Jaime-Figueroa , Rama Kondru , Yan Lou , Stephen Lynch , Timothy D. Owens , Michael Soth , Calvin Yee
IPC分类号: A61K31/4985 , C07D295/155 , C07D491/107 , A61K31/541 , A61P29/00 , A61P37/00 , A61P35/00 , A61P25/00 , A61P9/00 , A61P3/10 , A61P37/04 , A61P11/06 , A61P19/04 , A61P17/06 , A61P37/06 , A61P17/00 , A61P5/14 , A61P1/04 , A61P1/00 , A61P25/28 , A61P35/02 , C07D487/04
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R, R2, and R3 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量Q和R,R2和R3如本文所述定义,其抑制JAK和SYK,并且可用于治疗自身免疫和炎性疾病 。
-
公开(公告)号:US08008298B2
公开(公告)日:2011-08-30
申请号:US12378977
申请日:2009-02-20
申请人: Joe Timothy Bamberg , Daisy Joe DuBois , Todd Richard Elworthy , Robert Than Hendricks , Johannes Cornelius Hermann , Alam Jahangir , Rama K. Kondru , Remy Lemoine , Yan Lou , Timothy D. Owens , David Bernard Smith , Michael Soth , Hanbiao Yang
发明人: Joe Timothy Bamberg , Daisy Joe DuBois , Todd Richard Elworthy , Robert Than Hendricks , Johannes Cornelius Hermann , Alam Jahangir , Rama K. Kondru , Remy Lemoine , Yan Lou , Timothy D. Owens , David Bernard Smith , Michael Soth , Hanbiao Yang
IPC分类号: A61K31/495
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q1, R, and X are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
摘要翻译: 本发明涉及式I的新型吡咯并吡嗪衍生物的用途,其中变量Q1,R和X如本文所述定义,其抑制JAK和SYK并且可用于治疗自身免疫和炎性疾病。
-
公开(公告)号:US20090215788A1
公开(公告)日:2009-08-27
申请号:US12378971
申请日:2009-02-20
申请人: Todd Richard Elworthy , Robert Than Hendricks , Rama K. Kondru , Yan Lou , Timothy D. Owens , Michael Soth , Hanbiao Yang
发明人: Todd Richard Elworthy , Robert Than Hendricks , Rama K. Kondru , Yan Lou , Timothy D. Owens , Michael Soth , Hanbiao Yang
IPC分类号: A61K31/4985 , C07D487/04
CPC分类号: C07D487/04
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
-
公开(公告)号:US20090215750A1
公开(公告)日:2009-08-27
申请号:US12378978
申请日:2009-02-20
申请人: Joe Timothy Bamberg , Mark Bartlett , Daisy Joe DuBois , Todd Richard Elworthy , Robert Than Hendricks , Johannes Cornelius Hermann , Rama K. Kondru , Remy Lemoine , Yan Lou , Timothy D. Owens , Jaehyeon Park , David Bernard Smith , Michael Soth , Hanbiao Yang , Calvin Wesley Yee
发明人: Joe Timothy Bamberg , Mark Bartlett , Daisy Joe DuBois , Todd Richard Elworthy , Robert Than Hendricks , Johannes Cornelius Hermann , Rama K. Kondru , Remy Lemoine , Yan Lou , Timothy D. Owens , Jaehyeon Park , David Bernard Smith , Michael Soth , Hanbiao Yang , Calvin Wesley Yee
IPC分类号: A61K31/4985 , C07D487/04 , A61P29/00 , A61K31/541 , A61K31/5377 , A61K31/55
CPC分类号: C07D487/04 , C07D519/00
摘要: The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
-
-
-
-
-
-
-
-
-